UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 22, 2005
CVS CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-01011 | 05-0494040 | |
(Commission File Number) | (IRS Employer Identification No.) |
One CVS Drive Woonsocket, Rhode Island |
02895 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (401) 765-1500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. | Regulation FD Disclosure |
On December 22, 2005, CVS Corporation issued a press release confirming that it has been in discussions with Albertsons, Inc., regarding a purchase of Albertsons standalone Sav-on and Osco drugstores, however no agreement on any transaction between CVS and Albertsons has been reached. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Corporations related press release dated December 22, 2005.
The information in this report is being furnished, not filed. Accordingly, the information in Item 9.01 of this report will not be incorporated by reference into any registration statement filed by the Corporation under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit No. |
Description | |
99.1 | Press Release, dated December 22, 2005. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CVS CORPORATION | ||
By: | /s/ DAVID B. RICKARD | |
David B. Rickard | ||
Executive Vice President, Chief Financial Officer and Chief Administrative Officer | ||
Dated: December 22, 2005 |